Bristol-Myers Squibb Company
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Last updated:

Abstract:

Compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFN.alpha., by acting on Tyk-2 to cause signal transduction inhibition. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

17 Nov 2016

Issue date:

19 Nov 2019